SMT201700108B - Derivati delle mostarde azotate - Google Patents
Derivati delle mostarde azotateInfo
- Publication number
- SMT201700108B SMT201700108B SM201700108T SM201700108T SMT201700108B SM T201700108 B SMT201700108 B SM T201700108B SM 201700108 T SM201700108 T SM 201700108T SM 201700108 T SM201700108 T SM 201700108T SM T201700108 B SMT201700108 B SM T201700108B
- Authority
- SM
- San Marino
- Prior art keywords
- mostards
- derivatives
- nitrogen
- nitrogen mostards
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Pregnancy & Childbirth (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161540523P | 2011-09-28 | 2011-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT201700108B true SMT201700108B (it) | 2017-03-08 |
Family
ID=47996730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM201700108T SMT201700108B (it) | 2011-09-28 | 2017-02-16 | Derivati delle mostarde azotate |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8962855B2 (it) |
| EP (1) | EP2760860B8 (it) |
| JP (1) | JP6008972B2 (it) |
| AR (1) | AR088075A1 (it) |
| AU (1) | AU2012316084B2 (it) |
| CA (1) | CA2850541C (it) |
| CY (1) | CY1118626T1 (it) |
| DK (1) | DK2760860T3 (it) |
| ES (1) | ES2616242T3 (it) |
| HR (1) | HRP20170196T1 (it) |
| HU (1) | HUE031445T2 (it) |
| IL (1) | IL231170A (it) |
| LT (1) | LT2760860T (it) |
| MX (1) | MX342746B (it) |
| PL (1) | PL2760860T3 (it) |
| PT (1) | PT2760860T (it) |
| RS (1) | RS55680B1 (it) |
| SI (1) | SI2760860T1 (it) |
| SM (1) | SMT201700108B (it) |
| TW (1) | TW201326162A (it) |
| WO (1) | WO2013049279A2 (it) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2519517B1 (en) | 2009-12-29 | 2015-03-25 | Dana-Farber Cancer Institute, Inc. | Type ii raf kinase inhibitors |
| TWI573792B (zh) | 2012-02-01 | 2017-03-11 | 歐陸斯迪公司 | 新穎治療劑 |
| CN104693256B (zh) * | 2013-12-04 | 2018-07-10 | 杭州源昶医药科技有限公司 | 吉西他滨衍生物、含该衍生物的组合物及所述衍生物的制药用途 |
| CN106659765B (zh) | 2014-04-04 | 2021-08-13 | 德玛医药 | 二脱水半乳糖醇及其类似物或衍生物用于治疗非小细胞肺癌和卵巢癌的用途 |
| GB201409485D0 (en) | 2014-05-28 | 2014-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| GB201409488D0 (en) | 2014-05-28 | 2014-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| GB201409471D0 (en) | 2014-05-28 | 2014-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| EP4019515A1 (en) * | 2015-09-09 | 2022-06-29 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
| WO2018068832A1 (en) | 2016-10-11 | 2018-04-19 | Euro-Celtique S.A. | Hodgkin lymphoma therapy |
| GB201709402D0 (en) | 2017-06-13 | 2017-07-26 | Euro Celtique Sa | Compounds for treating t-pll |
| GB201709405D0 (en) | 2017-06-13 | 2017-07-26 | Euro Celtique Sa | Compounds for treating ovarian cancer |
| GB201709403D0 (en) | 2017-06-13 | 2017-07-26 | Euro Celtique Sa | Compounds for treating sarcoma |
| GB201709406D0 (en) | 2017-06-13 | 2017-07-26 | Euro-Cletique S A | Compounds for treating TNBC |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5882941A (en) | 1994-05-04 | 1999-03-16 | Massachusette Institute Of Technology | Programmable genotoxic agents and uses therefor |
| US6214852B1 (en) * | 1998-10-21 | 2001-04-10 | Bristol-Myers Squibb Company | N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| US6392053B2 (en) | 1999-12-15 | 2002-05-21 | Bristol-Myers Squibb Company | Process for preparing arylacetylaminothiazoles |
| SG174772A1 (en) * | 2006-09-11 | 2011-10-28 | Curis Inc | Multi-functional small molecules as anti-proliferative agents |
| TW200922564A (en) | 2007-09-10 | 2009-06-01 | Curis Inc | CDK inhibitors containing a zinc binding moiety |
| US8309554B2 (en) * | 2008-05-15 | 2012-11-13 | Threshold Pharmaceuticals | Hypoxia activated drugs of nitrogen mustard alkylators |
| WO2010075542A1 (en) | 2008-12-23 | 2010-07-01 | Curis, Inc. | Cdk inhibitors |
-
2012
- 2012-09-27 LT LTEP12836986.5T patent/LT2760860T/lt unknown
- 2012-09-27 PT PT128369865T patent/PT2760860T/pt unknown
- 2012-09-27 SI SI201230831A patent/SI2760860T1/sl unknown
- 2012-09-27 DK DK12836986.5T patent/DK2760860T3/en active
- 2012-09-27 EP EP12836986.5A patent/EP2760860B8/en active Active
- 2012-09-27 US US14/347,397 patent/US8962855B2/en active Active
- 2012-09-27 HU HUE12836986A patent/HUE031445T2/en unknown
- 2012-09-27 MX MX2014003839A patent/MX342746B/es active IP Right Grant
- 2012-09-27 WO PCT/US2012/057445 patent/WO2013049279A2/en active Application Filing
- 2012-09-27 RS RS20170167A patent/RS55680B1/sr unknown
- 2012-09-27 JP JP2014533702A patent/JP6008972B2/ja active Active
- 2012-09-27 AR ARP120103588A patent/AR088075A1/es not_active Application Discontinuation
- 2012-09-27 ES ES12836986.5T patent/ES2616242T3/es active Active
- 2012-09-27 CA CA2850541A patent/CA2850541C/en active Active
- 2012-09-27 PL PL12836986T patent/PL2760860T3/pl unknown
- 2012-09-27 TW TW101135740A patent/TW201326162A/zh unknown
- 2012-09-27 AU AU2012316084A patent/AU2012316084B2/en active Active
-
2014
- 2014-02-26 IL IL231170A patent/IL231170A/en active IP Right Grant
-
2017
- 2017-02-07 HR HRP20170196TT patent/HRP20170196T1/hr unknown
- 2017-02-10 CY CY20171100187T patent/CY1118626T1/el unknown
- 2017-02-16 SM SM201700108T patent/SMT201700108B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2014003839A (es) | 2015-01-16 |
| ES2616242T3 (es) | 2017-06-12 |
| MX342746B (es) | 2016-10-11 |
| CY1118626T1 (el) | 2017-07-12 |
| TW201326162A (zh) | 2013-07-01 |
| CA2850541C (en) | 2019-11-05 |
| US8962855B2 (en) | 2015-02-24 |
| JP6008972B2 (ja) | 2016-10-19 |
| PT2760860T (pt) | 2017-02-21 |
| SI2760860T1 (sl) | 2017-04-26 |
| IL231170A0 (en) | 2014-04-30 |
| EP2760860B1 (en) | 2016-11-16 |
| AU2012316084A1 (en) | 2014-03-20 |
| IL231170A (en) | 2015-07-30 |
| JP2014528003A (ja) | 2014-10-23 |
| HRP20170196T1 (hr) | 2017-04-07 |
| US20140303218A1 (en) | 2014-10-09 |
| WO2013049279A2 (en) | 2013-04-04 |
| PL2760860T3 (pl) | 2017-06-30 |
| EP2760860A2 (en) | 2014-08-06 |
| HUE031445T2 (en) | 2017-07-28 |
| AR088075A1 (es) | 2014-05-07 |
| DK2760860T3 (en) | 2017-02-27 |
| AU2012316084B2 (en) | 2016-10-27 |
| RS55680B1 (sr) | 2017-07-31 |
| EP2760860B8 (en) | 2017-03-08 |
| CA2850541A1 (en) | 2013-04-04 |
| EP2760860A4 (en) | 2015-04-22 |
| LT2760860T (lt) | 2017-03-10 |
| WO2013049279A3 (en) | 2013-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201700108B (it) | Derivati delle mostarde azotate | |
| FR22C1047I2 (fr) | Derives de benzimidazole-proline | |
| SMT201500270B (it) | Derivati di pirrolotriazinone come inibitori di pi3k | |
| SMT201600020B (it) | Derivati di benzilammina come inibitori di callicreina plasmatica | |
| SMT201600418B (it) | Derivati di tienopiridone come attivatori della ampk | |
| SMT201600099B (it) | Derivati citotossici di benzodiazepine | |
| SMT201600198B (it) | Derivati di 1,2,4-triazina-4-ammina | |
| SMT201600108B (it) | Derivato di pirazochinolina come inibitori di pde9 | |
| SMT201600205B (it) | DERIVATI BENZOTIOFENICI SOSTITUITI CON PIPERAZINA COME AGENTI ANTlPSICOTICI | |
| DK3235812T3 (da) | Deutererede derivater af ivacaftor | |
| CO6890099A2 (es) | Nuevos derivados dihidroquinolina-2-ona | |
| DK3415157T3 (da) | N-acyldipeptidderivater og anvendelser deraf | |
| DK2814849T3 (da) | Fremgangsmåde til fremstilling af cyclodextrin-derivater | |
| AR092198A1 (es) | Derivados de pirazolopirimidinas | |
| CO6990717A2 (es) | Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina | |
| DK2900645T3 (da) | Herbicidt aktive 3-phenylisoxazolinderivater | |
| DK3450434T3 (da) | Deutererede derivater af ruxolitinib | |
| SMT201500208B (it) | Derivati di piridinone come inibitori della transglutaminasi tissutale | |
| BR112014013850A2 (pt) | conjunto de prateleiras | |
| DK2917181T3 (da) | Heteroarylderivater og anvendelser deraf | |
| SMT201600076B (it) | Derivati di 2-osso-1-pirrolidinil imidazotiadiazolo | |
| DK2646452T3 (da) | Chlorering af carbohydrater og carbohydratderivater | |
| ITMI20112329A1 (it) | Nuovi derivati spiro amminici | |
| CO6960557A2 (es) | Derivados de 2-yodo-imidazol | |
| SMT201600405B (it) | Derivati di arilalchilamminocarbossammide fluorurati |